Related Experiment Videos
Introduction to the issues: new potential contaminants and other exogenous agents
1CBER/FDA, Bethesda, MD 20892.
Developments in Biological Standardization
|January 1, 1992
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Rapid differentiation of MOGAD and MS after a single optic neuritis.
Journal of neurology·2024
Pro- and anti-inflammatory macrophages express a sub-type specific purinergic receptor profile.
Purinergic signalling·2021
[Muscle weakness and CK elevation: is it myositis?]
Zeitschrift fur Rheumatologie·2020
Cerebrospinal fluid findings in reversible cerebral vasoconstriction syndrome: a way to differentiate from cerebral vasculitis?
Clinical and experimental immunology·2018
International challenges and public policy issues.
Developments in biological standardization·2000
Standardisation and licensing of combination vaccines based on DTP.
Developments in biological standardization·2000
The transmissible spongiform encephalopathy agents: concerns and responses of United States regulatory agencies in maintaining the safety of biologics.
Developments in biological standardization·2000
Cytokine and growth factor standardization: the need for research to answer modern issues.
Developments in biological standardization·2000
Alternatives to the use of animals for bacterial toxins and antitoxins.
Developments in biological standardization·2000
Cell substrates: lessons learned and challenges remaining.
Developments in biological standardization·2000
Research progress on the regulation of sludge bulking by quorum sensing.
Ying yong sheng tai xue bao = The journal of applied ecology·2026
Phytoplankton community responses to sub-inhibitory levels of four contaminants of emerging concern.
Journal of plankton research·2026